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Histology 
 Adenocarcinoma 2208 46.3 246950 37.5
 Squamous 557 11.7 179428 27.3
 Large Cell 443 9.3 45796 7.0
 BAC 156 3.3 23836 3.6
 NSCLC 578 12.1 93666 14.2
 Other 827 17.3 68306 10.4
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Objective: The aims of this study were to describe histological and 
clinical characteristics of lung cancer patients and its impact on diag-
nosis in the western region of Mexico over a period of four years and 
compare them with those historical series of other regions of Mexico 
and other countries.
Patients and methods: We studied retrospectively 1312 cases with 
clinical diagnosis of lung cancer, from the Department of pulmonary 
physiology (Western National Medical Center), from January 2002 to 
December 2005. Statistic analysis: Gender and age was compared with 
x2 test. Differences between diagnostic methods were established using 
comparative contingency tables. P value less than 0.05 was considered 
statistically signiﬁcant.
Results: Accordingly gender, 57% of lung cancer patients were men 
and 43% women. The average age was 51 years old. 14.3% had a 
deﬁnitive diagnosis of lung cancer. The average of analyzed samples 
for each patient was 1.67; nevertheless, there was cases with until 
8 samples. The average of patients with deﬁnitive diagnosis of lung 
cancer per year was 46.5 from 323. The most common histological 
type of lung cancer was adenocarcinoma (65%), followed by squamous 
cell lung cancer (20%). The most frequent diagnostic methods were: 
bronchial aspirate, pleural cytology and bronchial biopsy. Our study 
reveals statistical differences on frequency of lung cancer histological 
types compared with reports from Finland, Poland, Turkey, Spain and 
United States of America. Otherwise, the comparison between studies 
from other regions of our country and these results present similar 
frequencies.
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Harsal, Asrul; Suratman, Eddy; Tambunan, Tagor 
Dharmais National Cancer Hospital, Jakarta, Indonesia
Background: Lung cancer is the ﬁrst cause of death in cancer patient, 
and Lung cancer mostly diagnosed at late stage, and survival was poor. 
To know the characteristic of lung cancer in our institution, we evalu-
ated lung cancer patient about, gender ratio, mean age, stage, type of 
cytology, distant metastatic, treatment and others.
Methods: From January 2004 to December 2004, we collected and 
analyzed the data ﬁles of lung cancer patient. This is the retrospective 
study, some data not completely.
Results: From total of 67 patients, 51 pts are man and 16 pts are 
woman, and average age 57 years old. The type of cancer are; SCLC 4 
% and NSCLC 96 %.
All SCLC are extensive stage, with brain metastatic, and NSCLC, stage 
IIIA; 2 %, IIIB; 46% and stage IV:52%.From the available data, cytol-
ogy ﬁndings are; Adenocarcinoma: 54 %, Squamous Cell Ca:22 %, 
Large cell Ca:4 %, and no describe the type of cytology: 20 %. Distant 
metastatic are bones: 19 pts, brain; 6 pts, liver; 5 pts, and contra lateral 
of lung: 5 pts. Chemotherapy was given to 23 pts (34 %), chemoradia-
tion for 2 pts (3%), and palliative radiotherapy for brain metastatic 
and bones;19 pts (28 %). Combination of chemotherapy was platinum 
based ( cisplatin or carboplatin) combined with etoposide, paclitaxel, 
gemcitabine, docetaxel, and irinotecan ) as ﬁrst or second line chemo-
therapy, one patients got Geﬁtinib after chemotherapy. 
Conclusion: Mostly diagnosis of lung cancer stage IIIB and IV. The 
type of cytology; Adenocarconoma is predominant, the four sites for 
metastatic are bones, liver, brain and lung, chemotherapy and target 
therapy was given for 34 % of patient.
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Background: We have observed increasing rate of patients suffer-
ing from multiple primary carcinomas over the last ten years.The aim 
of this study was to ﬁnd signiﬁcant frequencies of various malignant 
tumour associations, as well as common risk factors, evaluation of 
therapy, prognosis and survival of patients with conﬁrmed lung cancer 
and additional primary malignancies.
Patients and Methods: This metastudy included 142 patients suffering 
from more than one primary carcinoma (synchronous or metachro-
nous appearance), where one of the tumours was histopathologically 
conﬁrmed lung cancer. Patients were registered in our department 
between 1995 and the fall of 2006. We have analysed their gender, age, 
family history, smoking status, date of the ﬁrst malignancy, as well as 
the timing of the secondary (or tertiary) malignancies. In addition we 
have observed the most frequent mutual associations of the tumours, 
outcome of therapy, survival rates, etc.
Results: There were 118 men and 24 women, age ranging from 26 to 
79 years. The longest interval between each carcinoma diagnoses was 
29 years (larynx and lung cancer) and 26 years (malignant lymphoma 
and lung cancer). The shortest interval corresponded to a simultaneous 
occurrence of lung cancer duplicity with different morphology. Median 
time interval between malignant tumours was 3 years.
Discussion: In our group predominance of men (83%) is evident, 
which could be explained by pre-selection of lung carcinoma be-
ing more common in men. 84% of patients were smokers (current or 
